Boston Financial Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $226K | Sell |
5,034
-1,111
| -18% | -$62.3K | 0.01% | 312 |
|
|
2024
Q3 | $386K | Sell |
6,145
-641
| -9% | -$37.4K | 0.01% | 265 |
|
|
2024
Q2 | $401K | Sell |
6,786
-581
| -8% | -$36.3K | 0.01% | 256 |
|
|
2024
Q1 | $588K | Buy |
7,367
+677
| +10% | +$51.7K | 0.02% | 234 |
|
|
2023
Q4 | $528K | Sell |
6,690
-207
| -3% | -$14.7K | 0.02% | 234 |
|
|
2023
Q3 | $482K | Sell |
6,897
-6,439
| -48% | -$456K | 0.02% | 225 |
|
|
2023
Q2 | $922K | Buy |
13,336
+1,149
| +9% | +$81.8K | 0.03% | 192 |
|
|
2023
Q1 | $906K | Sell |
12,187
-1,009
| -8% | -$84.6K | 0.04% | 183 |
|
|
2022
Q4 | $1.23M | Sell |
13,196
-1,357
| -9% | -$131K | 0.05% | 162 |
|
|
2022
Q3 | $1.39M | Buy |
14,553
+853
| +6% | +$84.4K | 0.06% | 149 |
|
|
2022
Q2 | $1.27M | Buy |
13,700
+3,740
| +38% | +$365K | 0.05% | 143 |
|
|
2022
Q1 | $1.01M | Buy |
9,960
+1,563
| +19% | +$164K | 0.04% | 164 |
|
|
2021
Q4 | $866K | Sell |
8,397
-1,250
| -13% | -$116K | 0.03% | 154 |
|
|
2021
Q3 | $819K | Buy |
9,647
+3,192
| +49% | +$267K | 0.03% | 149 |
|
|
2021
Q2 | $539K | Sell |
6,455
-250
| -4% | -$20.5K | 0.02% | 172 |
|
|
2021
Q1 | $504K | Sell |
6,705
-2,000
| -23% | -$146K | 0.02% | 167 |
|
|
2020
Q4 | $595K | Sell |
8,705
-3,901
| -31% | -$254K | 0.03% | 153 |
|
|
2020
Q3 | $736K | Sell |
12,606
-3,045
| -19% | -$189K | 0.04% | 139 |
|
|
2020
Q2 | $1.02M | Sell |
15,651
-1,637
| -9% | -$103K | 0.05% | 120 |
|
|
2020
Q1 | $1.03M | Sell |
17,288
-7,297
| -30% | -$487K | 0.07% | 115 |
|
|
2019
Q4 | $1.83M | Sell |
24,585
-2,570
| -9% | -$180K | 0.1% | 110 |
|
|
2019
Q3 | $1.71M | Sell |
27,155
-75
| -0.3% | -$4.44K | 0.1% | 116 |
|
|
2019
Q2 | $1.48M | Sell |
27,230
-10,090
| -27% | -$543K | 0.09% | 122 |
|
|
2019
Q1 | $2.01M | Sell |
37,320
-5,020
| -12% | -$310K | 0.12% | 114 |
|
|
2018
Q4 | $2.77M | Buy |
42,340
+185
| +0.4% | +$13.8K | 0.19% | 101 |
|
|
2018
Q3 | $3.32M | Sell |
42,155
-2,216
| -5% | -$158K | 0.2% | 106 |
|
|
2018
Q2 | $2.85M | Sell |
44,371
-715
| -2% | -$47.1K | 0.19% | 111 |
|
|
2018
Q1 | $2.81M | Sell |
45,086
-4,323
| -9% | -$310K | 0.19% | 119 |
|
|
2017
Q4 | $3.58M | Sell |
49,409
-3,532
| -7% | -$257K | 0.24% | 112 |
|
|
2017
Q3 | $4.3M | Sell |
52,941
-11,893
| -18% | -$941K | 0.31% | 104 |
|
|
2017
Q2 | $5.22M | Sell |
64,834
-15,951
| -20% | -$1.26M | 0.37% | 95 |
|
|
2017
Q1 | $6.34M | Sell |
80,785
-38,520
| -32% | -$3.08M | 0.47% | 75 |
|
|
2016
Q4 | $9.41M | Sell |
119,305
-7,013
| -6% | -$567K | 0.74% | 40 |
|
|
2016
Q3 | $11.2M | Sell |
126,318
-8,769
| -6% | -$828K | 0.92% | 25 |
|
|
2016
Q2 | $12.9M | Buy |
135,087
+4,834
| +4% | +$482K | 1.05% | 23 |
|
|
2016
Q1 | $13.5M | Sell |
130,253
-2,974
| -2% | -$289K | 2.03% | 5 |
|
|
2015
Q4 | $13M | Buy |
133,227
+1,239
| +0.9% | +$121K | 1.87% | 6 |
|
|
2015
Q3 | $12.7M | Sell |
131,988
-603
| -0.5% | -$63.4K | 1.8% | 7 |
|
|
2015
Q2 | $13.9M | Sell |
132,591
-913
| -0.7% | -$93.3K | 1.79% | 6 |
|
|
2015
Q1 | $13.8M | Sell |
133,504
-528
| -0.4% | -$53.4K | 1.72% | 6 |
|
|
2014
Q4 | $12.9M | Buy |
134,032
+1,860
| +1% | +$164K | 1.62% | 11 |
|
|
2014
Q3 | $10.5M | Sell |
132,172
-1,215
| -0.9% | -$95.8K | 1.38% | 14 |
|
|
2014
Q2 | $10.1M | Buy |
133,387
+1,640
| +1% | +$124K | 1.33% | 15 |
|
|
2014
Q1 | $9.86M | Buy |
131,747
+8,884
| +7% | +$628K | 1.32% | 15 |
|
|
2013
Q4 | $8.79M | Buy |
122,863
+4,608
| +4% | +$296K | 1.21% | 17 |
|
|
2013
Q3 | $6.71M | Sell |
118,255
-6,495
| -5% | -$387K | 1.01% | 25 |
|
|
2013
Q2 | $7.13M | Buy |
+124,750
| New | +$7.23M | 1.1% | 18 |
|
Other funds holding CVS
Boston Financial Management's CVS Position: Q4 2024 in Review
Boston Financial Management reduced its CVS Health (CVS) stake by 18% in Q4 2024, selling an estimated $62.3K and leaving 5,034 shares worth $226K. The position accounts for 0.01% of the portfolio, ranked #312.
Boston Financial Management first reported a position in CVS in Q2 2013 and has held it in 47 quarters since. The position peaked at $13.9M in Q2 2015. 1,669 funds tracked by Wall St. Rank hold CVS as of Q4 2024.
- Boston Financial Management held 5,034 shares of CVS Health worth $226K as of Q4 2024.
- Boston Financial Management sold 1,111 CVS Health shares in Q4 2024, an estimated $62.3K.
- CVS Health made up 0.01% of Boston Financial Management's portfolio in Q4 2024, its #312 holding.
- Boston Financial Management first reported a position in CVS Health in Q2 2013 and has held it in 47 quarters since.
- Boston Financial Management's CVS Health position peaked at $13.9M in Q2 2015.
- 1,669 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.
Based on Boston Financial Management's 13F filing for Q4 2024, filed 3 Feb 2025.